Intracellular production of hepatitis c e1 and e2 truncated...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/18 (2006.01) A61K 39/29 (2006.01) C07K 1/22 (2006.01) C12N 15/40 (2006.01) G01N 33/50 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2288374

Methods for obtaining recombinantly produced, C-terminally truncated, E1 and E2 polypeptides from cell lysates are disclosed. The intracellularly expressed truncated molecules display improved biological properties as compared to their secreted counterparts.

On décrit des procédés qui permettent de produire des polypeptides E1 et E2 tronqués à leur extrémité C-terminale, obtenus par recombinaison à partir de lysats cellulaires. Les molécules tronquées exprimées au niveau intracellulaire présentent des propriétés biologiques améliorées par comparaison avec leurs homologues secrétées.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intracellular production of hepatitis c e1 and e2 truncated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intracellular production of hepatitis c e1 and e2 truncated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracellular production of hepatitis c e1 and e2 truncated... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1342448

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.